Related Experiment Video

Updated: Jul 6, 2026

A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors
09:16

A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors

Published on: October 30, 2016

Reaching the unreached with measles vaccination

Peter Salama1, Jeff McFarland, Kim Mulholland

  • 1UNICEF, New York, NY 10017, USA. psalama@unicef.org

Lancet (London, England)
|September 6, 2005
PubMed
Summary

No abstract available in PubMed .

More Related Videos

Simultaneous Quantification of Anti-vector and Anti-transgene-Specific CD8+ T Cells Via MHC I Tetramer Staining After Vaccination with a Viral Vector
08:10

Simultaneous Quantification of Anti-vector and Anti-transgene-Specific CD8+ T Cells Via MHC I Tetramer Staining After Vaccination with a Viral Vector

Published on: November 28, 2018

Wet Beveling of Microinjection Needles Utilizing Constant Air Pressure for Feedback on Needle Opening
06:00

Wet Beveling of Microinjection Needles Utilizing Constant Air Pressure for Feedback on Needle Opening

Published on: September 27, 2024

Related Experiment Videos

Last Updated: Jul 6, 2026

A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors
09:16

A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors

Published on: October 30, 2016

Simultaneous Quantification of Anti-vector and Anti-transgene-Specific CD8+ T Cells Via MHC I Tetramer Staining After Vaccination with a Viral Vector
08:10

Simultaneous Quantification of Anti-vector and Anti-transgene-Specific CD8+ T Cells Via MHC I Tetramer Staining After Vaccination with a Viral Vector

Published on: November 28, 2018

Wet Beveling of Microinjection Needles Utilizing Constant Air Pressure for Feedback on Needle Opening
06:00

Wet Beveling of Microinjection Needles Utilizing Constant Air Pressure for Feedback on Needle Opening

Published on: September 27, 2024

Related Concept Videos

Vaccinations01:51

Vaccinations

Overview
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Rocky Mountain Spotted Fever01:26

Rocky Mountain Spotted Fever

Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.

Articles linked to this work by shared authors, journal, and citation graph.

Targeted pneumococcal conjugate vaccination strategies for high-risk children.

Human vaccines & immunotherapeutics·2026

Sustained and indirect effects of PCV10 reduced-dose schedules on pneumococcal carriage in Viet Nam: a long-term follow-up of a cluster-randomised controlled trial.

The Lancet. Infectious diseases·2026

Cellular immune responses 12 months after fractional or standard dose BNT162b2 booster vaccination in Mongolian adults.

Frontiers in immunology·2026

Effect of time-of-day vaccination on the antibody response to mRNA and protein COVID-19 vaccine in adults.

Vaccine·2026

Fractional BNT162b2 boosters induce durable immune responses after non-mRNA priming in Mongolia: a randomised controlled trial.

Frontiers in immunology·2026

Immunogenicity and efficacy over 12 months following a fourth dose of a bivalent mRNA or protein-based COVID-19 vaccine: A randomised controlled trial in Australia.

The Journal of infection·2026

Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Switch to once-weekly, single-tablet islatravir-lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial.

Lancet (London, England)·2026

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Lancet (London, England)·2026

Multivessel coronary artery bypass grafting via small thoracotomy versus sternotomy (MIST): an investigator-initiated, international, open-label, randomised controlled trial.

Lancet (London, England)·2026

Sustainable nanomedicine:green synthesis of functional nanomaterials and its applications.

Frontiers in chemistry·2026

Tuning protein corona on nucleic acid nanodrugs for targeted delivery.

Acta pharmaceutica Sinica. B·2026

Chemoinformatic and machine learning fusion for designing silver nanoparticles with enhanced antimicrobial properties.

3 Biotech·2026

Entropy and topological indices of nanostar dendrimers: a graph-theoretic approach.

Frontiers in chemistry·2026

Advance in One-Pot Synthesis of Polymer-Coated Nanogold: Au(III)-Monomer Redox Reaction Initiates Radical Polymerization and Produces a Potential Nanotag Platform.

Small (Weinheim an der Bergstrasse, Germany)·2026

The Fierce Morphological Battle of Silver Nanoparticles: How Irregularities, Vacancies and Defects Tip the Crossing Sizes.

Small (Weinheim an der Bergstrasse, Germany)·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us